These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 24461861)

  • 1. Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices.
    Mendes BC; Oderich GS; Fleming MD; Misra S; Duncan AA; Kalra M; Cha S; Gloviczki P
    J Vasc Surg; 2014 Feb; 59(2):359-367.e1. PubMed ID: 24461861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common femoral artery endarterectomy for lower-extremity ischemia: evaluating the need for additional distal limb revascularization.
    Malgor RD; Ricotta JJ; Bower TC; Oderich GS; Kalra M; Duncan AA; Gloviczki P
    Ann Vasc Surg; 2012 Oct; 26(7):946-56. PubMed ID: 22944568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of native superficial femoral artery chronic total occlusion recanalization after failed femoropopliteal bypass.
    Davies MG; El-Sayed HF
    J Vasc Surg; 2017 Mar; 65(3):726-733. PubMed ID: 28236917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of femoropopliteal stenting. Results of a prospective study.
    Schönefeld E; Torsello G; Osada N; Herten M; Bisdas T; Donas KP
    J Cardiovasc Surg (Torino); 2013 Oct; 54(5):617-23. PubMed ID: 24002391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
    Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
    J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
    Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
    J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The success of endovascular therapy for all TransAtlantic Society Consensus graded femoropopliteal lesions.
    Han DK; Shah TR; Ellozy SH; Vouyouka AG; Marin ML; Faries PL
    Ann Vasc Surg; 2011 Jan; 25(1):15-24. PubMed ID: 20932714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of femoropopliteal endovascular interventions on subsequent open bypass.
    Gifford SM; Fleming MD; Mendes BC; Stauffer KC; De Martino RR; Oderich GS; Gloviczki P; Bower TC
    J Vasc Surg; 2016 Sep; 64(3):623-8. PubMed ID: 27288105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
    Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
    J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of endovascular therapy for femoropopliteal disease with the Supera stent.
    Montero-Baker M; Ziomek GJ; Leon L; Gonzales A; Dieter RS; Gadd CL; Pacanowski JP
    J Vasc Surg; 2016 Oct; 64(4):1002-8. PubMed ID: 27444365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
    Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
    J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of bypass and endovascular interventions for advanced femoropopliteal disease in patients with premature peripheral artery disease.
    Kim TI; Zhang Y; Cardella JA; Guzman RJ; Ochoa Chaar CI
    J Vasc Surg; 2021 Dec; 74(6):1968-1977.e3. PubMed ID: 34090986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of femoropopliteal recurrence after routine and selective stenting endoluminal therapy.
    Kiguchi MM; Marone LK; Chaer RA; Winger DG; Shi ZY; Celis RI; Makaroun MS; Rhee RY
    J Vasc Surg; 2013 Jan; 57(1):37-43. PubMed ID: 22975333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary stenting for TASC C and D femoropopliteal lesions: one-year results from a multicentric trial on 203 patients.
    Brouillet J; Deloose K; Goueffic Y; Poirier M; Midy D; Caradu C; Ducasse E
    J Cardiovasc Surg (Torino); 2018 Jun; 59(3):392-404. PubMed ID: 27272981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
    Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
    J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
    Singh GD; Brinza EK; Hildebrand J; Waldo SW; Foley TR; Laird JR; Armstrong EJ
    J Endovasc Ther; 2017 Jun; 24(3):321-330. PubMed ID: 28421855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Long-term Outcomes of Heparin Bonded Polytetrafluoroethylene and Autologous Vein Below Knee Femoropopliteal Bypasses in Patients with Critical Limb Ischaemia.
    Uhl C; Grosch C; Hock C; Töpel I; Steinbauer M
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):203-211. PubMed ID: 28587797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.